RECURSION PHARMACEUTICALS-A
RXRXNASDAQ🏆 #1727 by market capEarnings Nov 3US Equity
$4.24▼ $0.11 (−2.53%)
🌙 After hours$4.11▼ 3.07%Regular close · extended-hours price shownTrack RXRX
Get earnings, price moves & breaking news on Telegram
24h▼ 2.5%
7d▲ 18.1%
14d▲ 2.2%
30d▲ 5.3%
ytd▲ 3.8%
1y▼ 27.9%
🏦Market Cap
$2.53B
Small Cap
📈Revenue Growth (YoY)
26.9%
High Growth
📊Gross Margin
-46.7%
Thin
💵FCF Margin
-645.8%
Thin
⚖️P/S Ratio
47.3x
Expensive
Otter Score
36
Weak
RECURSION PHARMACEUTICALS-A
RXRXAnalyst Ratings
Price
$4.24
Total
10
Raised
0
Lowered
0
Avg PT
$5.90
H / L
$6 / $6
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Needham | Reiterated | Buy | 2026-10-19 | $11.00 | +159.40% |
Morgan Stanley | Reiterated | Equal Weight | 2026-05-14 | $5.90 | +39.20% |
JP Morgan | Reiterated | Overweight | 2026-04-30 | — | — |
B of A Securities | Reiterated | Neutral | 2026-02-26 | — | — |
Leerink Partners | Reiterated | Market Perform | 2025-02-28 | $6.00 | +41.50% |
Keybanc | Reiterated | Overweight | 2025-01-08 | $12.00 | +183.00% |
Jefferies | Reiterated | Hold | 2024-09-03 | $6.00 | +41.50% |
Berenberg | Reiterated | Buy | 2023-07-12 | — | — |
SVB Leerink | Reiterated | Market Perform | 2023-01-23 | — | — |
Goldman Sachs | Reiterated | Neutral | 2022-11-09 | — | — |
Institution
Needham
Reiterated · Buy · 2026-10-19
$11.00
+159.40%
Morgan Stanley
Reiterated · Equal Weight · 2026-05-14
$5.90
+39.20%
JP Morgan
Reiterated · Overweight · 2026-04-30
—
—
B of A Securities
Reiterated · Neutral · 2026-02-26
—
—
Leerink Partners
Reiterated · Market Perform · 2025-02-28
$6.00
+41.50%
Keybanc
Reiterated · Overweight · 2025-01-08
$12.00
+183.00%
Jefferies
Reiterated · Hold · 2024-09-03
$6.00
+41.50%
Berenberg
Reiterated · Buy · 2023-07-12
—
—
SVB Leerink
Reiterated · Market Perform · 2023-01-23
—
—
Goldman Sachs
Reiterated · Neutral · 2022-11-09
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space